Sequins launches ctDNA Technology Access Program

Sequins launches ctDNA Technology Access Program

We are excited to launch our ctDNA Technology Access Program! This program a phased, collaborative framework designed to help clinical laboratories rapidly evaluate, optimize, and validate circulating tumor DNA (ctDNA) assays.

The program provides early access to Sequins’ ctDNA Evaluation Set, a next-generation internal standards solution that enables precise calibration, quantification, and determination of analytical sensitivity across liquid biopsy workflows. By embedding synthetic, mirrored variants across a VAF ladder that extends into low allele frequencies, Sequins allows laboratories to measure performance with unparalleled clarity – from library prep through sequencing and bioinformatic analysis.

To apply for this program, please visit https://sequins.bio/ctdna/ or contact us at enquiries@sequins.bio.